Merck KGaA (FRA: MRK) had its price objective raised by BMO Capital Markets from €51.00 ($66.23) to €54.00 ($70.13) in a research report released on Tuesday morning, Analyst Ratings Network.com reports. BMO Capital Markets currently has an outperform rating on the stock.
Several other analysts have also recently commented on the stock. Analysts at Jefferies Group upgraded shares of Merck KGaA from a hold rating to a buy rating in a research note to investors on Tuesday, May 28th. They now have a €54.00 ($70.13) price target on the stock, up previously from €48.00 ($62.34). Separately, analysts at JPMorgan Chase reiterated a neutral rating on shares of Merck KGaA in a research note to investors on Tuesday, May 28th. They now have a €120.00 ($155.84) price target on the stock. Finally, analysts at Morgan Stanley initiated coverage on shares of Merck KGaA in a research note to investors on Thursday, May 23rd. They set an overweight rating and a €142.00 ($184.42) price target on the stock.
Six analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. Merck KGaA currently has a consensus rating of Hold and a consensus target price of €103.87 ($134.89).
Shares of Merck KGaA (FRA: MRK) traded down 2.17% during mid-day trading on Tuesday, hitting €120.575. Merck KGaA has a one year low of €72.564 and a one year high of €125.629. The stock’s 50-day moving average is currently €94.50.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.